Prior studies using DCLK1-IN-1 treatment in pancreatic and colon cancer cell lines demonstrated that it has a limited ability to inhibit proliferation and colony formation in 2D cell cultures [17,18]. This evidence concerns the gene DCLK1 and malignant colon neoplasm.